Finance

Lists
SBS:FRA
Stratec SE
€22.15
+10.20%
(+2.05) 1D
Aug 14, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
€20.80
High
€22.15
Low
€20.80
Mkt. cap
269.97M
Avg. vol.
12.00
Volume
0.00
Dividend
2.71%
Quarterly dividend
€0.15
Ex-dividend date
Jun 24, 2026
52-wk high
€32.20
52-wk low
€16.38
Shares outstanding
11.96M
No. of employees
1K
Open
€20.80
High
€22.15
Low
€20.80
Mkt. cap
269.97M
Avg. vol.
12.00
Volume
0.00
Dividend
2.71%
Quarterly dividend
€0.15
Ex-dividend date
Jun 24, 2026
52-wk high
€32.20
52-wk low
€16.38
Shares outstanding
11.96M
No. of employees
1K
News stories
From web sources and news partners
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees1.4K
Founded1979
Headquarters-
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
57.00M
75.28M
53.43M
59.11M
Cost of goods sold
43.70M
56.31M
43.22M
43.87M
Cost of revenue
43.70M
56.31M
43.22M
43.87M
Research and development expenses
1.59M
2.78M
1.72M
1.49M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.47M
10.82M
8.82M
9.64M
Operating expense
9.78M
11.19M
10.30M
9.66M
Total operating expenses
53.48M
67.50M
53.53M
53.54M
Operating income
3.52M
7.78M
-104.00K
5.57M
Other non operating income
-117.00K
219.00K
-65.00K
116.00K
EBT including unusual items
2.38M
-826.00K
-1.16M
5.43M
EBT excluding unusual items
2.38M
5.55M
-1.16M
5.43M
Income tax expense
878.00K
3.52M
557.00K
1.27M
Effective tax rate
36.91%
-426.03%
-48.18%
23.35%
Other operating expenses
-274.00K
-2.41M
-235.00K
-1.46M
Net income
1.50M
-4.34M
-1.71M
4.16M
Net profit margin
2.63%
-5.77%
-3.21%
7.04%
Earnings per share
-
-
-
-
Interest and investment income
33.00K
8.00K
34.00K
-
Interest expense
-1.06M
-955.00K
-1.02M
-260.00K
Net interest expenses
-1.02M
-947.00K
-987.00K
-260.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
8.04M
10.71M
4.45M
10.03M
Gain or loss from assets sale
13.00K
3.00K
-94.00K
-9.00K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps